We found three kinases (CAMK2N1, GRK2, and MAP3K9) to be KGDs in OCC models, compared to other ovarian cancer histologies such as serous ovarian cancer (Figure S2; Table S1F). This evidence concerns the gene GRK2 and ovarian carcinoma.